09/24/2024
1:59 PM | Ionic Ventures, LLC (Filed by)
Vivos Therapeutics (Subject)
| Form SC 13G | |
09/20/2024
7:00 AM | Vivos Therapeutics (Filer)
| Form 424B5 | |
09/20/2024
7:05 AM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
7:00 AM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
4:00 PM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
3:24 PM | Vivos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
4:19 PM | Vivos Therapeutics (Filer)
| Form 424B1 | |
|
08/07/2024
11:15 PM | Vivos Therapeutics (Filer)
| Form EFFECT | |
07/29/2024
8:06 PM | Vivos Therapeutics (Filer)
| Form 10-K/A | |
07/30/2024
5:17 AM | Vivos Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/10/2024
7:00 AM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
7:53 PM | Amman Bradford K. (Reporting)
Vivos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
7:53 PM | Lindsay Mark F. (Reporting)
Vivos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
7:53 PM | Krammer Anja B (Reporting)
Vivos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
7:53 PM | Green Ralph Elias (Reporting)
Vivos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
7:53 PM | Thompson Matthew (Reporting)
Vivos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
7:53 PM | SOKOLOW LEONARD J (Reporting)
Vivos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
7:53 PM | Huntsman Ronald Kirk (Reporting)
Vivos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:30 PM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
1:54 PM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:16 PM | Vivos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2024
11:15 PM | Vivos Therapeutics (Filer)
| Form EFFECT | |
04/19/2024
6:52 PM | Vivos Therapeutics (Filer)
| Form S-1/A | |
04/08/2024
7:22 PM | Vivos Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/28/2024
7:38 PM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
7:55 AM | Vivos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
4:42 PM | Huntsman Ronald Kirk (Filed by)
Vivos Therapeutics (Subject)
Vivos Therapeutics (Subject)
| Form SC 13G/A | |
12/03/2023
11:15 PM | Vivos Therapeutics (Filer)
| Form EFFECT | |
11/22/2023
3:46 PM | Vivos Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
Free VVOS Stock Alerts